Soy isoflavones inhibit endothelial cell dysfunction and prevent cardiovascular disease. - GreenMedInfo Summary
Soy isoflavones inhibit endothelial cell dysfunction and prevent cardiovascular disease.
J Cardiovasc Pharmacol. 2019 Jul 22. Epub 2019 Jul 22. PMID: 31356541
Soybeans are among the most popular foods worldwide, and intake of soy-containing foods has been associated with many health benefits, in part because of it structure similar to estrogen. Epidemiologic studies have demonstrated that soy consumption improves serum profiles of hypercholesterolemic patients. Several studies have also indicated an inverse relationship between the consumption of soy isoflavones and the incidence of cardiovascular diseases (CVD). Soy is a rich dietary source of isoflavones. The main soy isoflavones are daidzein and genistein; equol, another isoflavone and a major intestinal bacterial metabolite of daidzein, is generated by enterobacterial effects. Many isoflavones have anti-oxidative effects and anti-inflammatory actions, as well as induce nitric oxide production to maintain a healthy endothelium and prevent endothelial cell dysfunction. These effects may limit the development of atherosclerosis and CVD and restore healthy endothelial function in altered endothelia. Although the evidence supporting the benefits of soy isoflavones in CVD prevention continues to increase, the association between soy isoflavones and disease is not fully understood. This review summarized recent progress in identifying the preventive mechanisms of action of dietary soybean isoflavones on vascular endothelial cells. Furthermore, it describe the beneficial roles that these isoflavones may have on endothelial dysfunction-related atherosclerosis.